BlossomHill Therapeutics, Inc. (BLSM) vs Immix Biopharma, Inc. (IMMX)

A side-by-side comparison of BlossomHill Therapeutics, Inc. and Immix Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
BlossomHill Therapeutics, Inc. logo
BLSM
BlossomHill Therapeutics, Inc.
$548M
$18.85HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT
Immix Biopharma, Inc. logo
IMMX
Immix Biopharma, Inc.
$528M
$9.70HealthcareDelayed quote: Oct 6, 2026, 12:25 PM EDT

Total return — BLSM vs IMMX

growth of $100 · dividends reinvested · last 1y
BLSM +24.6% (+24.6%/yr)IMMX +0.7% (+0.7%/yr)BLSM compounded faster over this window
100120140160Start $100$125$101
BLSM IMMX

BLSM vs IMMX: by the numbers

  • •BLSM is the larger company ($548M vs $528M market cap).

Metrics side by side

Valuation

MetricBLSMIMMX
P/B ratioN/A2.31

Profitability

MetricBLSMIMMX
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-17.44%
ROIC-43.41%-18.20%

Go deeper

Full BLSM analysisFull IMMX analysisInteractive comparison tool

Dig into the metrics

BlossomHill Therapeutics ROEImmix Biopharma ROEBlossomHill Therapeutics operating marginImmix Biopharma operating marginBlossomHill Therapeutics revenue growthImmix Biopharma revenue growthBlossomHill Therapeutics free cash flowImmix Biopharma free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.